Cleared Traditional

HARVEY-BOSTWICK BRADY CARDIA MONIT. HB85 (K821942) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K821942 · Harvey-Bostwick, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1982
Decision
56d
Days
Class 2
Risk

K821942 is an FDA 510(k) clearance for the HARVEY-BOSTWICK BRADY CARDIA MONIT. HB85. Classified as Monitor, Cardiac (incl. Cardiotachometer & Rate Alarm) (product code DRT), Class II - Special Controls.

Submitted by Harvey-Bostwick, Inc. (Mchenry, US). The FDA issued a Cleared decision on August 24, 1982 after a review of 56 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Harvey-Bostwick, Inc. devices

Submission Details

510(k) Number K821942 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 29, 1982
Decision Date August 24, 1982
Days to Decision 56 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
69d faster than avg
Panel avg: 125d · This submission: 56d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DRT Monitor, Cardiac (incl. Cardiotachometer & Rate Alarm)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRT Monitor, Cardiac (incl. Cardiotachometer & Rate Alarm)

All 69
Devices cleared under the same product code (DRT) and FDA review panel - the closest regulatory comparables to K821942.
NEUROMEDICS PACETRON HEART RATE MONITOR
K823290 · Intermedics, Inc. · Dec 1982
MODEL 78534A PATIENT MONITOR
K822876 · Hewlett-Packard Co. · Oct 1982
SIGNAL DISTRIBUTION NETWORK #78581A
K822695 · Hewlett-Packard Co. · Oct 1982
MODELS 78504A & 78508A PATIENT MON. SYS
K821368 · Hewlett-Packard Co. · May 1982
CARDIAC MONITOR - RATE ALARM
K820825 · Hewlett-Packard Co. · Apr 1982
#505 PORT. VITAL FUNCTIONS NEONATAL MON
K820416 · Ge Medical Systems Information Technologies · Mar 1982